LEADER 03156nam  22006375  450 
001 9910733734303321
005 20230613191751.0
010   $a3-319-49712-X
024 7 $a10.1007/978-3-319-49712-9
035   $a(CKB)3710000001064937
035   $a(DE-He213)978-3-319-49712-9
035   $a(MiAaPQ)EBC4804586
035   $a(Au-PeEL)EBL4804586
035   $a(CaPaEBR)ebr11345092
035   $a(OCoLC)973830816
035   $a(PPN)198871015
035   $a(EXLCZ)993710000001064937
100   $a20170213d2017      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aProgress in the Chemistry of Organic Natural Products 105 /$fedited by A. Douglas Kinghorn, Heinz Falk, Simon Gibbons, Jun'ichi Kobayashi
205   $a1st ed. 2017.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017.
215   $a1 online resource (V, 215 p. 120 illus., 59 illus. in color.) 
225 1 $aProgress in the Chemistry of Organic Natural Products,$x2192-4309 ;$v105
311   $a3-319-49711-1 
327   $aXanthine Alkaloids: occurrence, biosynthesis, and function in plants -- The Iboga Alkaloids -- A critical evaluation of the quality of published 13C-NMR-Data in natural product chemistry.
330   $aThe first contribution reviews the occurrence of xanthine alkaloids in the plant kingdom and the elucidation of the caffeine biosynthesis pathway, providing details of the N-methyltransferases, belonging to the motif B' methyltransferase family which catalyze three steps in the four step pathway leading from xanthosine to caffeine. The second contribution in this book provides a background on the molecule and related compounds and update knowledge on the most recent advances in Iboga alkaloids. The third contribution presents a comprehensive analysis of frequently occurring errors with respect to 13C NMR spectroscopic data and proposes a straightforward protocol to eliminate a high percentage of the most obvious errors.
410  0$aProgress in the Chemistry of Organic Natural Products,$x2192-4309 ;$v105
606   $aChemistry, Organic
606   $aPharmaceutical chemistry
606   $aMedicinal chemistry
606   $aOrganic Chemistry
606   $aPharmaceutics
606   $aMedicinal Chemistry
615  0$aChemistry, Organic.
615  0$aPharmaceutical chemistry.
615  0$aMedicinal chemistry.
615 14$aOrganic Chemistry.
615 24$aPharmaceutics.
615 24$aMedicinal Chemistry.
676   $a547
702   $aKinghorn$b A. Douglas$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aFalk$b Heinz$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aGibbons$b Simon$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aKobayashi$b Jun'ichi$4edt$4http://id.loc.gov/vocabulary/relators/edt
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910733734303321
996   $aProgress in the Chemistry of Organic Natural Products 105$93393770
997   $aUNINA